We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Enzo Patent Invalid Due To Sale Of Technology Prior To Issuance

Law360 (October 3, 2005, 12:00 AM EDT) -- A patent for disease-diagnosing probes, asserted by Enzo Biochem Inc., is invalid due to a controversial transaction made more than a year before it was issued, the U.S. Court of Appeals for the Federal Circuit has ruled.

Enzo sued Gen-Probe Incorporated and Becton Dickinson and Company in June 1999 in the U.S. District Court for the Southern District of New York, claiming its patent for a gonorrhoeae-detecting nucleic acid probe had been infringed.

In July 2004, the district judge found the transaction between New York-based Enzo...
To view the full article, register now.